BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18094557)

  • 1. Relationship between in vitro chemosensitivity assessed with MTT assay and clinical outcomes in 103 patients with acute leukemia.
    Jun KR; Jang S; Chi HS; Lee KH; Lee JH; Choi SJ; Seo JJ; Moon HN; Im HJ; Park CJ
    Korean J Lab Med; 2007 Apr; 27(2):89-95. PubMed ID: 18094557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol.
    Mihal V; Hajduch M; Noskova V; Janostakova A; Safarova M; Orel M; Kouzmina G; Stary J; Blazek B; Pospisilova D
    Bull Cancer; 2004 Apr; 91(4):E80-9. PubMed ID: 15562558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test.
    Hwang WS; Chen LM; Huang SH; Wang CC; Tseng MT
    Leuk Res; 1993 Aug; 17(8):685-8. PubMed ID: 8355513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.
    Pieters R; Loonen AH; Huismans DR; Broekema GJ; Dirven MW; Heyenbrok MW; Hählen K; Veerman AJ
    Blood; 1990 Dec; 76(11):2327-36. PubMed ID: 2257305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia.
    Styczynski J; Wysocki M; Debski R; Juraszewska E; Malinowska I; Stanczak E; Ploszynska A; Stefaniak J; Mazur B; Szczepanski T
    Leuk Lymphoma; 2002 Sep; 43(9):1843-8. PubMed ID: 12685842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
    Styczynski J; Pieters R; Huismans DR; Schuurhuis GJ; Wysocki M; Veerman AJ
    Br J Haematol; 2000 Sep; 110(4):813-8. PubMed ID: 11054062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of glufosfamide in childhood acute leukemia.
    Styczynski J; Wysocki M; Kurylak A; Juraszewska E; Malinowska I; Stanczak E; Płoszynska A; Stefaniak J; Mazur B; Szczepanski T; Ras M
    Anticancer Res; 2002; 22(1A):247-50. PubMed ID: 12017297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias.
    Fazlina N; Maha A; Jamal R; Zarina AL; Cheong SK; Hamidah H; Ainoon O; Zulkifli SZ; Hamidah NH
    Hematology; 2007 Feb; 12(1):33-7. PubMed ID: 17364990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of in vitro cellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan.
    Chen SH; Yang CP; Jaing TH; Hung IJ; Shih LY; Ho PC; Lee WI; Huang JL
    Leuk Lymphoma; 2012 Aug; 53(8):1536-42. PubMed ID: 22260162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.
    Klumper E; Pieters R; Kaspers GJ; Huismans DR; Loonen AH; Rottier MM; van Wering ER; van der Does-van den Berg A; Hählen K; Creutzig U
    Leukemia; 1995 Nov; 9(11):1864-9. PubMed ID: 7475276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of blast cell survival and proliferation to chemotherapy resistance in AML.
    Nørgaard JM; Langkjer ST; Palshof T; Clausen N; Pedersen B; Hokland P
    Br J Haematol; 1996 Jun; 93(4):888-97. PubMed ID: 8703822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
    Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
    Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.
    Leahey AM; Bunin NJ; Belasco JB; Meek R; Scher C; Lange BJ
    Med Pediatr Oncol; 2000 May; 34(5):313-8. PubMed ID: 10797352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia.
    Savaşan S; Buck S; Ozdemir O; Hamre M; Asselin B; Pullen J; Ravindranath Y
    Leuk Lymphoma; 2005 Jun; 46(6):833-40. PubMed ID: 16019527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of intracellular idarubicin and daunorubicin levels on drug cytotoxicity in childhood acute leukemia.
    Styczyński J; Wysocki M; Debski R; Kurylak A; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk J; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
    Acta Biochim Pol; 2002; 49(1):99-107. PubMed ID: 12136962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukaemia cell drug resistance and prognostic factors in AML.
    Nørgaard JM; Olesen G; Kristensen JS; Pedersen B; Hokland P
    Eur J Haematol; 1999 Oct; 63(4):219-24. PubMed ID: 10530409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
    Rasekh EO; Osman R; Ibraheem D; Madney Y; Radwan E; Gameel A; Abdelhafiz A; Kamel A; Elfishawi S
    Ann Hematol; 2021 Mar; 100(3):699-707. PubMed ID: 33230570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment results with ALL-BFM-95 protocol in children with acute lymphoblastic leukemia in Hungary].
    Müller J; Kovács G; Jakab Z; Rényi I; Galántai I; Békési A; Kiss C; Nagy K; Kajtár P; Bartyik K; Masát P; Magyarosy E
    Orv Hetil; 2005 Jan; 146(2):75-80. PubMed ID: 15724956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphenotypic acute leukemia treated with acute myeloid leukemia regimens: a case series.
    Serefhanoglu S; Buyukasik Y; Goker H; Sayinalp N; Ozcebe OI
    J Natl Med Assoc; 2009 Mar; 101(3):270-2. PubMed ID: 19331261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-resistance to five glucocorticoids in childhood acute lymphoblastic and non-lymphoblastic leukemia samples tested by the MTT assay: preliminary report.
    Styczyński J; Wysocki M; Debski R; Balwierz W; Rokicka-Milewska R; Matysiak M; Balcerska A; Kowalczyk J; Wachowiak J; Sońta-Jakimczyk D; Chybicka A
    Acta Biochim Pol; 2002; 49(1):93-8. PubMed ID: 12136961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.